Matthew Hershenhorn

Stock Analyst at Oppenheimer

(0.37)
# 4,092
Out of 4,876 analysts
1
Total ratings
n/a
Success rate
-5.28%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $103.36
Upside: +78.99%